Overview
Primary Health Properties Plc is a UK-based investment company specializing in the real estate sector, particularly focusing on the management, acquisition, and development of properties that are leased to primary healthcare facilities. Predominantly operating within the UK and Ireland, the company's portfolio primarily includes modern, purpose-built primary healthcare facilities such as doctor surgeries, clinics, and pharmacies. As a real estate investment trust (REIT), the company aims to provide high-quality spaces for healthcare providers while ensuring sustainable shareholder returns through stable rental incomes and property value appreciation. Key projects typically involve developing and refurbishing properties to meet contemporary healthcare demands, aligning with governmental health infrastructure goals to enhance community health services.
AI+ Ask Fintel’s AI assistant about Primary Health Properties Plc.
Thinking about good questions…
Basic Stats
The share price of Primary Health Properties Plc as of 05 September 2025 is R2 111,00 / share. This is a decrease of -4.74% from the prior week. The market cap (or net worth) of Primary Health Properties Plc as of 05 September 2025 is R2 844 072,00 MM.
The Factor Analysis chart (below right) shows a view of Primary Health Properties Plc from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 2,844,072.00 MM |
| EV | |
| Shares Out. | 1,336.50 MM |
| Earnings Date | |
| EPS (TTM) | 0.07 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-07-03 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -9.64 % |
| Volatility (1 yr) | 0.70 |
| Beta | 0.06 |
| Sharpe Ratio (1 yr) | -0.20 |
| Sortino Ratio (1 yr) | -0.33 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.03 |
| ROE | 0.07 |
| ROIC | 0.03 |
| CROIC | 0.00 |
| OCROIC | 0.05 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 50.70 /100 |
| Profitability | 49.79 /100 |
| Quality Score | 42.30 /100 |
| Value Score | |
| Momentum Score | 22.25 /100 |
| Stability (Low Vol) Score | |
| Analyst Sentiment | 1.05 /100 |
| Fund Sentiment | 69.48 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Primary Health Properties Plc is R32,73. The forecasts range from a low of R25,99 to a high of R38,14. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Primary Health Properties Plc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-03-01 | JP Morgan Cazenove | Neutral | Initiate | |
| 2024-02-09 | Berenberg Bank | Buy | Reiterate | |
| 2023-05-25 | Barclays | Underweight | Reiterate | |
| 2023-02-27 | Berenberg Bank | Hold | Reiterate | |
| 2022-08-31 | Berenberg Bank | Hold | Reiterate | |
| 2022-07-04 | Barclays | Overweight | Reiterate | |
| 2022-05-23 | Barclays | Overweight | Reiterate | |
| 2022-05-06 | Barclays | Overweight | Reiterate | |
| 2022-04-19 | Barclays | Overweight | Reiterate | |
| 2022-03-31 | Berenberg Bank | Hold | Reiterate | |
| 2022-03-21 | Barclays | Overweight | Reiterate | |
| 2022-03-11 | Barclays | Overweight | Reiterate | |
| 2022-03-08 | Barclays | Overweight | Reiterate | |
| 2022-02-15 | Barclays | Overweight | Reiterate | |
| 2022-02-15 | Barclays | Reiteration | Reiterate | |
| 2022-02-11 | Peel Hunt Limited | Buy | Reiterate | |
| 2022-02-11 | Peel Hunt Limited | Reiteration | Reiterate | |
| 2022-02-03 | Barclays | Reiteration | Reiterate | |
| 2022-01-24 | Barclays | Reiteration | Reiterate | |
| 2021-12-08 | Liberum Capital | Reiteration | Reiterate | |
| 2021-11-24 | Liberum Capital | Reiteration | Reiterate | |
| 2021-10-29 | Barclays | Overweight | Reiterate | |
| 2021-10-28 | Peel Hunt LLP | Buy | Reiterate | |
| 2021-08-04 | Berenberg Bank | Hold | Reiterate | |
| 2021-07-28 | Liberum Capital | Buy | Reiterate | |
| 2021-05-12 | Liberum Capital | Buy | Reiterate | |
| 2021-05-12 | Numis | Add | Reiterate | |
| 2021-02-17 | Jefferies | Buy | Reiterate | |
| 2020-02-12 | Peel Hunt LLP | Add | Reiterate | |
| 2019-11-29 | Berenberg Bank | Hold | Initiate | |
| 2018-10-30 | Peel Hunt LLP | Buy | Reiterate | |
| 2018-07-12 | Peel Hunt LLP | Buy | Reiterate | |
| 2018-03-23 | Liberum Capital | Hold | Reiterate | |
| 2016-07-04 | Liberum Capital | Hold | Reiterate | |
| 2015-12-01 | Liberum Capital | Hold | Reiterate | |
| 2014-12-04 | Liberum Capital | Hold | Reiterate | |
| 2014-11-11 | Liberum Capital | Hold | Reiterate | |
| 2014-10-21 | Liberum Capital | Hold | Reiterate | |
| 2014-09-16 | Oriel Securities | Hold | Reiterate | |
| 2014-08-21 | Liberum Capital | Hold | Reiterate | |
| 2014-08-04 | Liberum Capital | Hold | Reiterate | |
| 2014-06-17 | Liberum Capital | Hold | Reiterate | |
| 2014-04-10 | Liberum Capital | Hold | Reiterate | |
| 2014-02-21 | Liberum Capital | Hold | Reiterate | |
| 2013-12-12 | Liberum Capital | Hold | Reiterate | |
| 2013-11-15 | Liberum Capital | Hold | Reiterate | |
| 2013-11-06 | Liberum Capital | Hold | Initiate | |
| 2013-08-22 | Investec | Hold | Reiterate | |
| 2025-08-07 | Shore Capital | Buy | Reiterate | |
| 2024-09-18 | Berenberg Bank | Buy | Reiterate | |
| 2024-07-24 | Shore Capital | Buy | Reiterate | |
| 2024-08-05 | Berenberg Bank | Buy | Reiterate | |
| 2024-10-16 | Shore Capital | Buy | Reiterate | |
| 2025-04-10 | Shore Capital | Buy | Reiterate | |
| 2025-09-03 | Shore Capital | Buy | Reiterate | |
| 2025-05-19 | Shore Capital | Buy | Reiterate |
